Management strategies for three patients with gynecological malignancies during the outbreak of COVID-19
10.3760/cma.j.cn112141-20200302-00168
- VernacularTitle:妇科恶性肿瘤伴新型冠状病毒肺炎三例临床分析及其管理对策探讨
- Author:
Jun ZHANG
1
;
Peng PENG
;
Xing LI
;
Yunfei ZHA
;
Yang XIANG
;
Guonan ZHANG
;
Yan ZHANG
Author Information
1. 武汉大学人民医院妇产科 430060
- From:
Chinese Journal of Obstetrics and Gynecology
2020;55(4):221-226
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the management strategies for patients with gynecological malignant tumors during the outbreak and transmission of COVID-19.Methods:We retrospectively analyzed the clinical characteristics, treatment, and disease outcomes of three patients with gynecological malignancies associated with COVID-19 in Renmin Hospital of Wuhan University, and proposed management strategies for patients with gynecological tumors underriskof COVID-19.Results:Based on the national diagnosis and treatment protocol as well as research progress for COVID-19, three patients with COVID-19 were treated. Meanwhile, they were also appropriately adjusted the treatment plan in accordance with the clinical guidelines for gynecological tumors. Pneumonia was cured in 2 patients, and one patient died of COVID-19.Conclusions:Patients with gynecological malignant tumors are high-risk groups prone to COVID-19, and gynecological oncologists need to carry out education, prevention, control and treatment according to specific conditions. While, actively preventing and controlling COVID-19, the diagnosis and treatment of gynecological malignant tumors should be carried out in an orderly and safe manner.
